AbstractHIVInternational Workshop on HIV Pediatrics 2020“Right under our nose”: A simple screening tool to identify HIV-positive children outside of the PMTCT program at outpatient departments in MalawiView Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2020Point of Care SAMBA-II vs Centralized Laboratory Viral Load Assays among HIV-1 Infected Children, Adolescents and Young Adults in Rural Zimbabwe: A Randomized Controlled TrialView Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2020A validated outpatient department HIV screening tool for children 18 months to 14 years as efficient as index testing in UgandaView Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2020The “DTGs” of DTG for children and adolescents living with HIV (CALHIV): Descriptions, Trends, and Gaps of rolling out dolutegravir in CALHIV in Mbeya, Tanzania.View Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2020Acceptability of a new 4-in-1 Abacavir/Lamivudine/Lopinavir/Ritonavir paediatric fixed-dose combination: the caregiver-child dyads’ perspectiveView Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2020Safety, pharmacokinetics and acceptability of the ABC/3YC/LPV/R granules (4-in-1) in children living with HIV (3-20kg) in Uganda: LOLIPOP studyView Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2020Safety, pharmacokinetics, and efficacy of low-dose E/C/F/TAF in virologically suppressed children ≥2 years old living with HIVView Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2020Pediatric dolutegravir (DTG) dosing recommendations derived from combined P1093 and ODYSSEY Population Pharmacokinetic analysisView Abstract
AbstractHIVInternational Workshop on HIV Pediatrics 2020Twenty-four week safety, tolerability and efficacy of dolutegravir dispersible tablets in children 4 weeks to <6 years old with HIV: results from IMPAACT P1093View Abstract
PosterHIVInternational Workshop on HIV Pediatrics 2020High Prevalence of Hepatic Steatosis in Children with Perinatally Acquired HIV Starting Antiretroviral Therapy Beyond InfancyView Poster
PosterHIVInternational Workshop on HIV Pediatrics 2020High HIV infection rates among children under five years of age identified as TB presumptive in sub-Saharan AfricaView Poster
PosterHIVInternational Workshop on HIV Pediatrics 2020Characteristics and outcomes of coinfection-exposed infants born to women living with HIV in the UKView Poster
